Skip to main content

For investors

Turn brand equity into an underwritten growth thesis.

Fabaía helps investors determine whether a brand has credible licensing potential, where that potential exists, what capabilities are required and how licensing could contribute to the value-creation plan.

We work with private-equity and growth-equity firms, family offices, holding companies and portfolio-company leadership teams. Our work supports decision quality; we do not project valuation outcomes, returns or investment performance.

The route map

Where licensing enters the investment lifecycle

Licensing is examined differently at each stage. The question, the evidence standard and the deliverable change as the decision changes.

  1. 01

    Target screening

    A fast, structured read on whether a brand carries extension permission beyond its current categories, and whether licensing is worth diligence spend at all.

    Is there a licensing angle worth testing?

  2. 02

    Commercial due diligence

    Evidence-led assessment of category demand, comparable programmes, partner availability, royalty assumptions and the execution capability the plan would require.

    Does the licensing case hold under scrutiny?

  3. 03

    Investment-thesis development

    Translate findings into a sequenced thesis: which categories and markets, in what order, with what investment, and what would have to be true for each step.

    What would we underwrite, and on what basis?

  4. 04

    First 100 days

    A prioritised plan covering governance, approval workflow, partner pipeline and the decisions management should not defer past the first quarter.

    What must be in place before scale is attempted?

  5. 05

    Portfolio value creation

    Review licensing across multiple holdings: where programmes are under-managed, where terms are inconsistent, and where shared capability would reduce duplicated effort.

    Where is value being left unmanaged across the portfolio?

  6. 06

    Exit preparation

    Assess whether licensing revenue is documented, contracted, transferable and governed well enough to be examined by a buyer without discount.

    Would this programme survive a buyer's diligence?

Investor services

Five investor-focused modules

Each module answers a specific investor question, states its analytical approach, names its deliverables and identifies the management decision it supports.

  • Screen

    Licensing Opportunity Screen

    Investor questionDoes this brand have credible licensing potential, and is that potential large enough to matter to the thesis?

    Analytical approach

    Structured screen of brand permission, category adjacency, competitive licensing activity and observable demand signals, scored against a consistent rubric so several targets can be compared on the same basis.

    Deliverables

    • Licensing potential scorecard
    • Category adjacency map with permission ratings
    • Comparable-programme shortlist
    • Screening memo with confidence levels and evidence gaps

    Decision it supports

    Whether to carry licensing into full diligence, park it as a post-close option, or exclude it from the thesis.

  • Diligence

    Licensing Commercial Due Diligence

    Investor questionDo the licensing assumptions in the model hold up against category evidence, partner reality and execution requirements?

    Analytical approach

    Bottom-up testing of category demand, retail and channel structure, partner availability and quality, contract terms, royalty benchmarks and the internal capability the plan assumes. Assumptions are stated with their sources and their uncertainty.

    Deliverables

    • Category and market prioritisation matrix
    • Comparable-programme analysis with royalty benchmark ranges
    • Partner landscape with capability and durability assessment
    • Revenue scenarios with explicit assumptions, ranges and sensitivities
    • Risk register covering IP, contractual, channel, regulatory and reputational exposure

    Decision it supports

    How much of the licensing case to underwrite, which assumptions to flag as conditions, and where price or structure should reflect execution risk.

  • Value creation

    Licensing Value-Creation Plan

    Investor questionIf licensing is a lever, what is the sequence, the investment required and the milestone path?

    Analytical approach

    Convert diligence findings into a prioritised plan: category and market sequencing, partner strategy, commercial terms policy, resourcing and the review points at which the plan is corrected or stopped.

    Deliverables

    • Sequenced value-creation roadmap with milestones
    • 100-day plan with owners and decision gates
    • Capability-gap assessment and resourcing options
    • Board-ready recommendation pack

    Decision it supports

    What management commits to in the first year, what capability is bought or built, and how progress is measured.

  • Portfolio

    Portfolio Licensing Review

    Investor questionAcross our holdings, where is licensing under-managed, inconsistently contracted or duplicating effort?

    Analytical approach

    Comparative review of licensing activity across companies: programme maturity, contract and royalty consistency, governance quality, reporting reliability and shared-capability opportunities.

    Deliverables

    • Portfolio-level licensing heat map
    • Contract and royalty consistency findings
    • Shared-capability and standardisation options
    • Prioritised intervention list by effort and expected impact

    Decision it supports

    Where to intervene first, what to standardise centrally, and which programmes need dedicated leadership.

  • Operating model

    Licensing Operating Model

    Investor questionDoes the company have the organisation, governance and controls to run a licensing programme at the scale the plan assumes?

    Analytical approach

    Assessment of approvals, quality control, royalty reporting and audit, brand governance and decision rights, benchmarked against the programme size the plan requires rather than the one that exists today.

    Deliverables

    • Capability-gap assessment against target programme scale
    • Target operating model with decision rights and workflow
    • Royalty reporting, audit and compliance control design
    • Hiring, fractional-leadership and interim options

    Decision it supports

    What organisational investment is required before scaling, and whether leadership capability is a condition of the plan.

What you receive

Tangible outputs, not narrative

Every engagement produces artefacts that can be read by an investment committee, challenged, and reused after close.

  • Licensing potential scorecards
  • Category and market prioritisation matrices
  • Comparable-programme analyses
  • Revenue scenarios with stated assumptions
  • Partner landscapes
  • Capability-gap assessments
  • Risk registers
  • 100-day plans
  • Board-ready recommendations

Scenarios are analytical ranges built on stated assumptions. They are not forecasts, guarantees or representations about valuation, returns or investment performance.

Field notes for investors

Investor insights

Working notes on how licensing is assessed, underwritten and governed. Published as they are completed.

  • Diligence

    What licensing commercial due diligence actually tests

    The difference between a category that looks attractive and a programme a competent partner would sign — and the evidence that separates them.

    In preparation

  • Capital

    Licensing as a capital-efficient growth lever

    Where licensing extends reach without carrying inventory, tooling or channel cost — and where that efficiency is overstated because execution cost is understated.

    In preparation

  • Permission

    Brand-extension permission: how far can this brand travel?

    How to test whether customers grant a brand the right to appear in an adjacent category, and how to recognise extensions that quietly erode the equity being monetised.

    In preparation

  • Assumptions

    Royalty assumptions and how they break

    Rate ranges, guaranteed minimums, deduction definitions and reporting lag — the model inputs most often carried forward without testing.

    In preparation

  • Readiness

    Organisational readiness for a licensing programme

    Approvals, quality control, royalty audit and decision rights. The capability questions that determine whether a signed plan is executable.

    In preparation

  • Risk

    Licensing risks a buyer will find

    Contract transferability, territory overlap, IP registration gaps, licensee conduct and channel conflict — examined before a buyer examines them.

    In preparation

Base camp — investors

Assess a portfolio brand

Tell us what decision is in front of you. We reply to qualified enquiries with an initial view and a proposed conversation.

Please do not disclose a confidential acquisition target. A sector and a description of the question are enough to begin; we can sign an NDA before anything specific is discussed.

Prefer email? Write to hola@fabaia.co